Biological consequences of a point mutation at codon 969 of the FMS gene

Leukemia Research

Volumn 22, Issue 4, 1998, Pages 365-372

  McGlynn, Hugh ^a   Baker, Andrew H ^b   Padua, Rose Ann ^c  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

FMS; Point mutation; Receptor binding; Tumorigenicity

Indexed keywords

CELL SURFACE RECEPTOR; INTERLEUKIN 3; PHENYLALANINE; TYROSINE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL TRANSFORMATION; CODON; GENE MUTATION; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE;

ANIMALS; BLOTTING, NORTHERN; CARCINOGENICITY TESTS; CELL LINE; CELL SURVIVAL; CODON; GENES, FMS; GENES, FOS; GENES, JUN; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-3; IODINE RADIOISOTOPES; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, NUDE; POINT MUTATION; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RNA;

EID: 0032052271     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00006-X     Document Type: Article

References (41)

1. [1] Baccarini M, Sabatini DM, App A, Rapp UR, Stanley ER. Colony stimulating factor-1 (CSF-1) stimulates temperature dependent phosphorylation and activation of the RAF-1 protooncogene product. EMBO J 1990;9:3649-57.
2. [2] Ashmun RA, Look AT, Roberts WM, Roussel MF, Seremetis SF, Ohtsuka M, Sherr CJ. Monoclonal antibodies to the human CSF-1 receptor (c-FMS proto-oncogene product) detect epitopes on normal rnononuclear phagocytes and on leukemic blast cells. Blood 1989;73:827 37.
3. [3] Baker AH, Ridge SA, Hoy T, Cachia PG, Culligan D, Baines P, Whittaker JA, Jacobs A, Padua RA. Expression of the colony stimulating factor-1 receptor in B lymphocytes. Oncogene 1993;8:371-8.
4. [4] Tial KJ, Lopen A. Slupsky J, Caw ley JC. c-FMS expression by B-cells, with particular reference to the hairy cells of hairy-cell leukaemia. Br J Haematol 1993;83:223-31.
5. [5] Stanley ER, Guilbert LJ, Tushinski RJ, Bartlemez SH. CSF-1 -a mononuclear phagocyte lineage specific hemopoietic growth factor. J Cell Biochem 1983;21:151-9.
6. [6] Arceci RJ, Shanahan F, Stanley ER, Pollard JW, Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc Natl Acad Sci USA 1989;86:8818-22.
7. [7] Pollard JW, Bartocci A, Arceci R, Orlofsky A, Ladner MB, Stanley ER. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 1987;330:484-6.
8. [8] Rettenmier CW, Sacca R, Furmati WL, Roussel MF, Holt JT, Neinhuis AW, Stanley ER, Sherr CJ. Expression of the c-FMS proto-oncogene product (colony stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines. J Clin Invest 1986;77:1740 6.
9. [9] Scholl SM, Crocker P, Tang R, Pouillart P, Pollard JW. Is colony stimulating factor-1 a key mediator of breast cancer invasion and metastasis. Mol Carcinog 1993;7:207-11.
10. [10] Kacinski BM, Kimberly AS, Carter D, Yee LD, Sapi E, King BL, Chambers SK, Jones MA, Pirro MH, Stanley ER, Rohrschneider LR. FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed in human breast carcinomas in vivo and in vitro. Oncogene 1991;6:941-52.
11. [11] Guilbert LJ, Stanley ER. The interaction of colony-stimulating factor-1 with bone marrow-derived macrophages. J Biol Chem 1986;261:4024 32.
12. [12] Sherr CJ. Colony stimulating factor-1 receptor. Blood 1990;75:1-12.
13. [13] Courtneige SA, Dhand R, Pilat D, Twamley GM, Waterfield MD, Roussel MF. Activation of Src family kinases by the colony stimulating factor-1 and their association with its receptor. EMBO J 1993;12:943-50.
14. [14] Heisterkamp N, Groffen J, Stephenson JR. Isolation of v-fms and its human cellular homologue. Virology 1983;126:248-58.
15. [15] Browning PJ, Bunn HF, Cline A, Shuman M, Neinhuis AW. 'Replacement' of COOH-terminal truncation of v-fms with c-FMS sequences markedly reduces transformation potential. Proc Natl Acad Sci USA 1986;83:7800-4.
16. [16] Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ. Transforming potential of the c-FMS proto-oncogene (CSF-1 receptor). Nature 1987;325:549-52.
17. [17] Roussel MF, Downing JR, Rettenmier CW, Sherr CJ. A point mutation in the extracellular domain of the CSF-1 receptor (c-FMS proto-oncogene product) activates its transformation potential. Cell 1988;55:979-88.
18. [18] Baker DA, Glover HR, Dibb NJ. Synergy between SCF or M-CSF with IL-3 or GM-CSF in FDC-P1 cells - a sensitive assay of transforming mutations of c-FMS. Leukemia 1994;8:141-50.
19. [19] Ridge SA, Worwood M, Oscier D, Jacobs A, Padua RA. FMS mutations in myelodysplastic, leukaemic, and normal subjects. Proc Natl Acad Sci USA 1990;87:1377-80.
20. [20] Tobal K, Pagliuca A, Bhatt B, Bailey N, Lay ton DM, Mufti GJ. Mutation of the FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukaemia. Leukemia 1990;4:486-9.
21. [21] Ridge SA, Cachia PG, Carter G, Hughes DC, Clark RE, Whittaker JA, Padua RA, Jacobs A. FMS (CSF-1 receptor) and RAS oncogene mutations following cytotoxic therapy for lymphoma. Blood 1990;76(Suppl. 1):244a.
22. [22] Baker AH, Ball S, Mc Glynn H, Whittaker J, Burnett AK, Padua RA. C-terminal mutations of FMS gene in B-cell disorders. Leukemia 1995;9:155-8.
23. [23] Taylor C, McGlynn H, Carter G, Baker AH, Warren N, Ridge SA, Owen G, Thompson E, Thompson PW, Jacobs A, Padua RA. RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia. Leukemia 1995;9:466-70.
24. [24] Dibb NJ, Green SM, Ralph P. Expression of v-fms and c-FMS in the haemopoietic cell tine FDC-P1. Growth Factors 1990;2:301-11.
25. [25] Ormerod MG, editor. Flow Cytometry, A Practical Approach. Oxford: IRL Press, 1990.
26. [26] Fasano O, Birnbaum D, Edlund L, Fogl J, Wigier M. New human transforming genes detected by a tumorigenicity assay. Mol Cell Biol 1984;4:1695-705.
27. [27] Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of bilogically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
28. [28] Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, A Laboratory Manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
29. [29] Ryder K, Lau LF, Nathans D. A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci USA 1988;85:1487-91.
30. [30] Miller AD, Curran T, Verma IM. c-FOS protein can induce cellular transformation, a novel mechanism of activation of a cellular oncogene, Cell 1984;36:51-60.
31. [31] Khalili K, Weinmann R. Shut-off of actin biosynthesis in adenovirus serotype-2-infected cells. J Mol Biol 1984;175:453-68.
32. [32] Varticovski L, Druker B, Morrison D, Cantiy L, Roberts T. The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase. Nature 1989;342:699-702.
33. [33] Reedjik M, Liu X, Pawson T. Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony stimulating factor-1 receptor. Mol Cell Biol 1990;10:5601-8.
34. [34] Downing JR, Reynolds AB. PDGF, CSF-1, and EGF induce tyrosine phosphorylation of p 120, a pp60src transformation-associated substrate. Oncogene 1991;6:607-13.
35. [35] Nakamura T, Lin L, Kharbanda S, Knopf J, Kufe D. Macrophage colony stimulating factor activates phosphatidylcholine hydrolysis by cytoplasmic phospholipase A2. EMBO J 1992;11:4917-22.
36. [36] Roussel MF, Cleveland JL, Shurtleff SA, Sherr CJ. MYC rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature 1991;353:361-3.
37. [37] Shurtleff SA, Downing JA, Rock CO, Hawkins SA, Roussel MF, Sherr CJ. Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidyinositol 3-kinase. EMBO J 1990;9:2415-21.
38. [38] Jamal S, Ziff E. Transactivation of c-FOS and β-actin genes by raf as a step in the early response to transmembrane signals. Nature 1990;344:463-6.
39. [39] Siegfried Z, Ziff EB. Altered transcriptional activity of c-FOS promoter plasmids in v-raf transformed NIH3T3 cells. Mol Cell Biol 1990;10:6073-8.
40. [40] Rettenmier CW, Roussel MF, Ashmun RA, Ralph P, Price K, Sherr CJ. Synthesis of membrane-bound colony stimulating factor (CSF-1) and downmodulation of CSF-1 receptors in NIH3T3 cells transformed by cotransfection of the human CSF-1 and c-FMS (CSF-1 receptor) genes. Mol Cell Biol 1987;7:2378-87.
41. [41] Wells A, Welsh JB, Lazer CS, Wiley HS, Gill GN. Ligand induced transformation by a noninternalizing epidermal growth factor receptor. Science 1990;247:962-4.